Mynd Healthcare

Report / Trial registry metadata

Predictors of Relapse of Ovarian, Peritoneal, and Fallopian Tube Cancers

This study concerns Fallopian Tube Cancer, Peritoneal Neoplasms, Epithelial Ovarian Cancer. Its registered status is completed. The planned measures below describe the study design, not demonstrated treatment effects.

What is being studied?

Conditions
Fallopian Tube Cancer, Peritoneal Neoplasms, Epithelial Ovarian Cancer
Study type
Observational

How is the study designed?

Enrollment
119 (actual)
Minimum age
18 Years
Eligibility sex
Female

What will the study measure?

  • Create a multi-institutional repository from which investigations of serum proteomic signature profiles of epithelial ovarian cancer and relapse will be developed and validated Assessment window: End of specimen collection

What can this record establish?

These are registered plans and status information. Enrollment marked estimated is a target, not a verified count of participants already studied. The measures listed do not establish that an intervention succeeded. Eligibility criteria and recruitment status must be checked against the full study record before considering participation.

Kind
Trial registry metadata
Identifier
NCT00086567
Status
COMPLETED

View original record ↗

Worldwide knowledge / Healthcare records